Melatonin from cerebrospinal fluid but not from blood reaches sheep cerebral tissues under physiological conditions

Journal of Neuroendocrinology

Volumn 26, Issue 3, 2014, Pages 151-163

  Legros, C ^a,b,c,d,e   Chesneau, D ^a,b,c,d   Boutin, J A ^e   Barc, C ^f   Malpaux, B ^a,b,c,d  

^a UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d IFCE   (France)

^e INSTITUT DE RECHERCHES SERVIER   (France)

^f CEMAGREF   (France)

Author keywords

Blood flow; Brain; Cerebrospinal fluid; Diffusion; in vivo scintigraphy; Melatonin; Sheep; Transport; Ventricles

Indexed keywords

IODINE 123; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN LEVEL; BRAIN SCINTISCANNING; BRAIN TISSUE; BRAIN VENTRICLE; CEREBROSPINAL FLUID FLOW; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIFFUSION; IN VIVO STUDY; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; SHEEP; TISSUE LEVEL; ANIMAL; BLOOD; BLOOD BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; FEMALE; METABOLISM; PHYSIOLOGY; SCINTISCANNING;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; FEMALE; MELATONIN; RADIONUCLIDE IMAGING; SHEEP;

EID: 84897901749     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12134     Document Type: Article

References (56)

1. Segal MB. The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell Mol Neurobiol 2000; 20: 183-196.
2. Lehman M, Silver R. CSF signaling in physiology and behavior. Prog Brain Res 2000; 125: 415-433.
3. Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004; 45: 545-552.
4. Wood JH. Neuroendocrinology of cerebrospinal fluid: peptides, steroids, and other hormones. Neurosurgery 1982; 11: 293-305.
5. Davson H, Segal MB. Physiology of the CSF and Blood-Brain-Barrier. CRC Pr I Llc, 1996.
6. Yuan X, Desiderio DM. Proteomics analysis of human cerebrospinal fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 815: 179-189.
7. Silver R, LeSauter J, Tresco PA, Lehman MN. A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 1996; 382: 810-813.
8. Fang J, Wang Y, Krueger JM. Effects of interleukin-1 beta on sleep are mediated by the type I receptor. Am J Physiol 1998; 274: R655-R660.
9. Coleman RJ, Reppert SM. CSF vasopressin rhythm is effectively insulated from osmotic regulation of plasma vasopressin. Am J Physiol 1985; 248: E346-E352.
10. Schwartz WJ, Reppert SM. Neural regulation of the circadian vasopressin rhythm in cerebrospinal fluid: a pre-eminent role for the suprachiasmatic nuclei. J Neurosci 1985; 5: 2771-2778.
11. Skinner DC, Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999; 140: 4399-4405.
12. Arendt J. Melatonin and the Mammalian Pineal Gland. London: Chapman & Hall, 1995.
13. Malpaux B. Seasonal regulation of reproduction in mammals. eds. Knobil and Neill's Physiology of Reproduction, 3rd edn. 2006: 2231-2281.
14. Tricoire H, Locatelli A, Chemineau P, Malpaux B. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology 2002; 143: 84-90.
15. Tricoire H, Moller M, Chemineau P, Malpaux B. Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod. Reprod Suppl 2003; 61: 311-321.
16. Maywood ES, Hastings MH. Lesions of the iodomelatonin-binding sites of the mediobasal hypothalamus spare the lactotropic, but block the gonadotropic response of male Syrian hamsters to short photoperiod and to melatonin. Endocrinology 1995; 136: 144-153.
17. Maywood ES, Bittman EL, Hastings MH. Lesions of the melatonin- and androgen-responsive tissue of the dorsomedial nucleus of the hypothalamus block the gonadal response of male Syrian hamsters to programmed infusions of melatonin. Biol Reprod 1996; 54: 470-477.
18. Malpaux B, Daveau A, Maurice-Mandon F, Duarte G, Chemineau P. Evidence that melatonin acts in the premammillary hypothalamic area to control reproduction in the ewe: presence of binding sites and stimulation of luteinizing hormone secretion by in situ microimplant delivery. Endocrinology 1998; 139: 1508-1516.
19. Dubocovich ML, Yun K, Al-Ghoul WM, Benloucif S, Masana MI. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 1998; 12: 1211-1220.
20. Hunt AE, Al-Ghoul WM, Gillette MU, Dubocovich ML. Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol 2001; 280: C110-C118.
21. Huang CC, Yang CH, Hsu KS. Do stress and long-term potentiation share the same molecular mechanisms? Mol Neurobiol 2005; 32: 223-235.
22. El-Sherif Y, Hogan MV, Tesoriero J, Wieraszko A. Factors regulating the influence of melatonin on hippocampal evoked potentials: comparative studies on different strains of mice. Brain Res 2002; 945: 191-201.
23. Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J. Inhibition of Alzheimer beta-fibrillogenesis by melatonin. J Biol Chem 1998; 273: 7185-7188.
24. Chen LJ, Gao YQ, Li XJ, Shen DH, Sun FY. Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro. J Pineal Res 2005; 39: 34-42.
25. Feng Z, Qin C, Chang Y, Zhang JT. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. Free Radic Biol Med 2006; 40: 101-109.
26. Rosales-Corral SA, Acuna-Castroviejo D, Coto-Montes A, Boga JA, Manchester LC, Fuentes-Broto L, Korkmaz A, Ma S, Tan DX, Reiter RJ. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin. J Pineal Res 2012; 52: 167-202.
27. Anton-Tay F, Wurtman RJ. Regional uptake of 3H-melatonin from blood or cerebrospinal fluid by rat brain. Nature 1969; 221: 474-475.
28. Anton-Tay F, Forray C, Ortega-Corona BG. Subneuronal fate of intracerebroventricular injected 3H-melatonin. J Pineal Res 1988; 5: 125-133.
29. 14C-melatonin in rat: a biochemical and autoradiographic study. J Pineal Res 1988; 5: 437-453.
30. Vakkuri O, Lamsa E, Rahkamaa E, Ruotsalainen H, Leppaluoto J. Iodinated melatonin: preparation and characterization of the molecular structure by mass and 1H NMR spectroscopy. Anal Biochem 1984; 142: 284-289.
31. Malpaux B, Daveau A, Maurice F, Locatelli A, Thiery JC. Evidence that melatonin binding sites in the pars tuberalis do not mediate the photoperiodic actions of melatonin on LH and prolactin secretion in ewes. J Reprod Fertil 1994; 101: 625-632.
32. Rollag MD, Morgan RJ, Niswender GD. Route of melatonin secretion in sheep. Endocrinology 1978; 102: 1-8.
33. Rollag MD, Niswender GD. Radioimmunoassay of serum concentrations of melatonin in sheep exposed to different lighting regimens. Endocrinology 1976; 98: 482-489.
34. 123I-scintigraphic imaging in rats explains its short circulatory half-life. Reprod Biol Endocrinol 2003; 1: 64.
35. Malpaux B, Robinson JE, Wayne NL, Karsch FJ. Regulation of the onset of the breeding season of the ewe: importance of long days and of an endogenous reproductive rhythm. J Endocrinol 1989; 122: 269-278.
36. Vollrath L. The pineal organ. In: Oksche A, Vollrath L, eds. Handbuch der mikroskopischen anatomie des menchen. Berlin: Springer-Verlag, 1981.
37. Longatti P, Perin A, Rizzo V, Comai S, Bertazzo A, Allegri G. Endoscopic selective sampling of human ventricular CSF: a new perspective. Minim Invasive Neurosurg 2004; 47: 350-354.
38. Longatti P, Perin A, Rizzo V, Comai S, Giusti P, Costa CV. Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique. J Pineal Res 2007; 42: 113-118.
39. Leston J, Harthe C, Brun J, Mottolese C, Mertens P, Sindou M, Claustrat B. Melatonin is released in the third ventricle in humans. A study in movement disorders. Neurosci Lett 2010; 469: 294-297.
40. Kurtcuoglu V, Soellinger M, Summers P, Boomsma K, Poulikakos D, Boesiger P, Ventikos Y. Computational investigation of subject-specific cerebrospinal fluid flow in the third ventricle and aqueduct of Sylvius. J Biomech 2007; 40: 1235-1245.
41. Laitinen JT, Saavedra JM. Characterization of melatonin receptors in the rat suprachiasmatic nuclei: modulation of affinity with cations and guanine nucleotides. Endocrinology 1990; 126: 2110-2115.
42. Piketty V, Pelletier J. Melatonin receptors in the lamb pars tuberalis/median eminence throughout the day. Neuroendocrinology 1993; 58: 359-365.
43. Mailliet F, Audinot V, Malpaux B, Bonnaud A, Delagrange P, Migaud M, Barrett P, Viaud-Massuard MC, Lesieur D, Lefoulon F, Renard P, Boutin JA. Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors. Biochem Pharmacol 2004; 67: 667-677.
44. Nonno R, Capsoni S, Lucini V, Moller M, Fraschini F, Stankov B. Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates. J Pineal Res 1995; 18: 207-216.
45. Morgan PJ, Barrett P, Howell HE, Helliwell R. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994; 24: 101-146.
46. Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 2010; 62: 343-380.
47. Masana MI, Dubocovich ML. Melatonin receptor signaling: finding the path through the dark. Sci STKE 2001; 2001: PE39.
48. Reiter RJ, Tan DX. What constitutes a physiological concentration of melatonin? J Pineal Res 2003; 34: 79-80.
49. Reiter RJ, Tan DX, Rosales-Corral S, Manchester LC. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem 2013; 13: 373-384.
50. Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JA. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000; 275: 31311-31317.
51. Nosjean O, Nicolas JP, Klupsch F, Delagrange P, Canet E, Boutin JA. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem Pharmacol 2001; 61: 1369-1379.
52. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. Melatonin. FEBS J 2006; 273: 2813-2838.
53. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005; 27: 179-188.
54. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
55. Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM. Human melatonin production decreases with age. J Pineal Res 1986; 3: 379-388.
56. Hardeland R. Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. ScientificWorldJournal 2012; 2012: 640389.